Subgroup Analysis of the Phase Ii Randomized Mcl-002 (Sprint) Study of Lenalidomide Vs Investigator's Choice in Relapsed/Refractory Mantle Cell Lymphoma
AuthID
P-00G-EW8
P-00G-EW8
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service